Overview Financials News + Filings Key Docs Charts Holdings Ownership Insiders
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Inv. presentation Appointed director Quarterly results Consulting agrmnt
|
ClearPoint Neuro, Inc. (CLPT)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/08/2023 |
8-K
| Quarterly results |
05/11/2023 |
8-K
| Quarterly results |
03/01/2023 |
8-K
| Quarterly results |
11/08/2022 |
8-K
| Quarterly results |
08/09/2022 |
8-K
| Quarterly results |
05/11/2022 |
8-K
| Quarterly results |
03/01/2022 |
8-K
| Quarterly results |
11/09/2021 |
8-K
| Investor presentation, Quarterly results |
05/11/2021 |
8-K
| Quarterly results |
03/04/2021 |
8-K
| Quarterly results |
08/12/2020 |
8-K
| Quarterly results |
05/13/2020 |
8-K
| Quarterly results |
05/15/2018 |
8-K
| Quarterly results |
03/15/2018 |
8-K
| Quarterly results |
11/06/2017 |
8-K
| Investor presentation, Quarterly results |
04/27/2017 |
8-K
| Form 8-K - Current report |
02/28/2017 |
8-K
| Form 8-K - Current report |
11/12/2013 |
8-K
| Quarterly results
Docs:
|
"MRI INTERVENTIONS ANNOUNCES THIRD QUARTER 2013 FINANCIAL RESULTS MEMPHIS, Tenn., November 12, 2013 – MRI Interventions, Inc. , a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended September 30, 2013. Management Comments “MRI Interventions had another very successful quarter. We achieved record product revenues in the quarter, including record revenues from both disposable product sales and capital product sales. We expanded the ClearPoint installed base in the quarter with four new installations, another company record, and we narrowed our operating loss in the quarter compared to the second quarter of..." |
|
08/13/2013 |
8-K
| Quarterly results
Docs:
|
"MRI INTERVENTIONS ANNOUNCES SECOND QUARTER 2013 FINANCIAL RESULTS MEMPHIS, Tenn., August 13, 2013 – MRI Interventions, Inc. , a commercial stage medical device company focused on creating innovative platforms for performing the next generation of minimally invasive surgical procedures in the brain and heart, announced today its financial results for the quarter ended June 30, 2013. Management Comments “We are very pleased with the progress we made in the second quarter. We posted record disposable product revenues, we added to our installed base, we advanced our activities in drug delivery trials, we introduced additional capabilities for our ClearPoint system and we continued to expand the sales and marketing platform we need to support future growth in our business,” said Kimble Jenkins,..." |
|
|
|